Back

Remnant cholesterol lowering in cardiovascular disease risk reduction in statin trials: meta-regression analyses

30 August 2024 (15:00 - 15:50)
Organised by: Logo
Congress Presentation Part of: Lipids as risk factor for heart disease Lipids ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Ask Tybjaerg Nordestgaard

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

7 More presentations in this session

Presentation thumbnail
Participation rate and yield of indirect cascade genetic screening for familial hypercholesterolemia using a web-based communication platform (CATCH): a randomized multicenter implementation trial
Assistant Professor D. Nanchen (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Burden and sociodemographic disparities in cardiovascular mortality rates associated with hypercholesterolemia in united states: a nationwide county-level analysis from 2010 to 2019
Doctor S. Abohashem (Boston, US)
Abstract Slides Video
Presentation thumbnail
Remnant cholesterol and cardiovascular and all-cause mortality in Korean adults
Professor B. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Impact of measured or calculated small dense LDL cholesterol compared with apolipoprotein B or non-HDL cholesterol for long-term secondary prevention in patients with stable coronary artery disease
Professor S. Koba (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Prognostic role of remnant cholesterol and traditional cardiovascular risk factors in young adults: results of long-term follow-up of a cohort of 30-year-old norwegians.
Doctor E. Aaseth (Oslo, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids as risk factor for heart disease

The Event

Event poster

ESC Congress 2024

30 August 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Remnant cholesterol in atherosclerotic cardiovascular disease: a systematic review and meta-analysis
thumbnail
Congress Presentation
Composition of non-HDL cholesterol and residual cardiovascular risk in secondary prevention
thumbnail
Congress Presentation
Elevated remnant cholesterol confers high risk of ASCVD without prompting lipid-lowering therapy: an unmet medical need

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources